Moreover, it has been shown that regulation of the RANKL/OPG ratio is one of the means by which bone resorption and formation can be maintained in equilibrium, and the RANKL/OPG ratio is indicative of osteoclastogenic activity in various bone remodeling diseases 1, 3, 52, 53. This evidence concerns the gene TNFRSF11B and bone remodeling disease.